Bio-Rad Laboratories (BIO) Capital Expenditures Growth (3y) (2012 - 2026)
Bio-Rad Laboratories (BIO) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 9.52% |
| 10 | Bio-Rad Laboratories | 10.07 Bn | 8.45 Bn | 345.80 Mn | -2.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.61% |
| Mar 31, 2026 | -5.66% |
| Dec 31, 2025 | 9.57% |
| Sep 30, 2025 | 4.76% |
| Jun 30, 2025 | 38.15% |
| Mar 31, 2025 | 1.31% |
| Dec 31, 2024 | -8.60% |
| Sep 30, 2024 | 5.10% |
| Jun 30, 2024 | 21.84% |
| Mar 31, 2024 | 27.17% |
| Dec 31, 2023 | -4.73% |
| Sep 30, 2023 | 30.18% |
| Jun 30, 2023 | 24.12% |
| Mar 31, 2023 | 18.28% |
| Dec 31, 2022 | 17.25% |
| Sep 30, 2022 | -3.92% |
| Jun 30, 2022 | -7.94% |
| Mar 31, 2022 | 11.87% |
| Dec 31, 2021 | 1.41% |
| Sep 30, 2021 | 16.23% |